Somatostatin was first discovered in hypothalamic extracts and identified as a substance that inhibited secretion of human growth hormone. Subsequently, it was found to be secreted by a broad range of tissues, including pancreas, intestinal tract and regions of the central nervous system outside the hypothalamus. It reduces HGH.
Structure and Synthesis
Two forms of somatostatin are synthesized. They are referred to as SS-14 and SS-28, reflecting their amino acid chain length. Both forms of it are generated by proteolytic cleavage of prosomatostatin, which itself is derived from preprosomatostatin. Two cysteine residules in SS-14 allow the peptide to form an internal disulfide bond. No one knows if HGH is affected by this bond.
The relative amounts of SS-14 versus SS-28 secreted depends upon the tissue. For example, SS-14 is the predominant form produced in the nervous system and apparently the sole form secreted from pancreas, whereas the intestine secretes mostly SS-28. The pituitary secretes HGH.
In addition to tissue-specific differences in secretion of SS-14 and SS-28, the two forms of this substance can have different biological potencies. SS-28 is roughly ten-fold more potent in inhibition of HGH, but less potent that SS-14 in inhibiting glucagon release.
Receptors and Mechanism of Action
Five stomatostatin receptors have been identified and characterized, all of which are members of the G protein-coupled receptor superfamily. Each of the receptors activates distinct signaling mechanisms within cells, although all inhibit adenylyl cyclase. Four of the five receptors do not differentiate SS-14 from SS-28. HGH is inhibited by it.
It works by both endocrine and paracrine pathways to affect its target cells. A majority of the circulating somatostatin appears to come from the pancreas and gastrointestinal tract. If one had to summarize the consequences of it in one phrase, it would be: "somatostatin inhibits the output of many other hormones".
Results on the Pituitary Gland
It was named for its outcome of inhibiting output of human growth hormone from the pituitary gland. Experimentally, all known stimuli for HGH secretion are suppressed by its administration. Additionally, animals treated with antisera to somatostatin show elevated blood concentrations of human growth hormone, as do animals that are genetically engineered to disrupt their somatostatin gene.
Ultimately, HGH secretion is controlled by the interaction of somatostatin and human growth hormone releasing hormone, both of which are secreted by hypothalamic neurons.
Effects on the Pancreas
Cells within pancreatic islets secrete insulin, glucagon and somatostatin. It appears to work primarily in a paracrine manner to inhibit the secretion of both insulin and glucagon. It also has the outcome of suppressing pancreatic exocrine secretions, by inhibiting cholecystokinin-stimulated enzyme secretion and secretin-stimulated bicarbonate secretion.
Effects on the Gastrointestinal Tract
It is secreted by scattered cells in the GI epithelium, and by neurons in the enteric nervous system. It has been shown to inhibit secretion of many of the other GI substances, including gastrin, cholecystokinin, secretin and vasoactive intestinal peptide.
In addition to the direct effects of inhibiting secretion of other GI hormones, it has a variety of other inhibitory effects on the GI tract, which may reflect its effects on other hormones, plus some additional direct results regarding HGH. It suppresses secretion of gastric acid and pepsin, lowers the rate of gastric emptying, and reduces smooth muscle contractions and blood flow within the intestine. Collectively, these motions seem to have the overall effect of decreasing the rate of nutrient absorption and HGH.
Effects on the Nervous System
It is often referred to has having neuromodulatory motion within the central nervous system, and appears to have a variety of complex effects on neural transmission. Injection into the brain of rodents leads to such things as increased arousal and decreased sleep, and impairment of some motor responses.
Its synthetic analogs are used clinically to treat a variety of neoplasms. It is also used in to treat giantism and acromegaly, due to its ability to inhibit HGH secretion.